Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 137.89 Delayed Data As of Mar 31 |  +1.86 / +1.37%Today’s Change | 61.28 Today|||52-Week Range 159.84 | +6.41% Year-to-Date |
Latest SRPT News | Press Releases
| Sarepta Therapeutics (SRPT) Down 6.2% Since Last Earnings Report: Can It Rebound? Mar 30 / Zacks.com - Paid Partner Content | Sarepta Therapeutics (SRPT) Soars 7.1%: Is Further Upside Left in the Stock? Mar 21 / Zacks.com - Paid Partner Content |
| 3 Up-and-Coming Growth Stocks to Buy Right Now Mar 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 136.03 |
| Today’s open | 136.71 |
| Day’s range | 136.71 - 139.19 |
| Volume | 40,428 |
| Average volume (3 months) | 1,230,343 |
| Market cap | $12.1B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -55.90% |
| Earnings growth (this year) | +36.05% |
| Earnings growth (next 5 years) | +67.30% |
| Revenue growth (last year) | +32.93% |
| P/E ratio | NM |
| Price/Sales | 12.16 |
| Price/Book | 31.49 |
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | -$1.33 |
| Annual revenue (last year) | $933.0M |
| Annual profit (last year) | -$703.5M |
| Net profit margin | -75.40% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
